Previous Close | 13.54 |
Open | 15.00 |
Bid | 0.00 x 0 |
Ask | 0.00 x 0 |
Day's Range | 13.54 - 13.54 |
52 Week Range | 12.33 - 17.81 |
Volume | |
Avg. Volume | 770 |
Market Cap | 4.455B |
Beta (5Y Monthly) | 0.80 |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | 0.46 (3.41%) |
Ex-Dividend Date | Jun 09, 2023 |
1y Target Est | N/A |
AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR Clariant publishes the Integrated Report 2023, detailing the company’s financial and non-financial business activities for the year.For ease of orientation, the report is now available in one concise PDF edition.In keeping with our mission to become leaders in sustainability and in consideration of new regulations, the report now contains additional metrics to monitor our progress.The Board of Directors will present the Integrated Report 2023 to the sha
AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR Q4 2023: Sales decreased by 10 % organically in local currency1 to CHF 1.062 billion against a strong comparable in Q4 2022; sequential sales increase of 4 % in local currency driven by volume growthQ4 2023: EBITDA margin of 10.0 % impacted by provisions related to sunliquid® decision and restructuring; underlying EBITDA margin before exceptional items of 14.9 %FY 2023: Sales decreased by 7 % organically in local currency to CHF 4.377 billion due to low
AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR Strategic review concluded: Board of Directors has decided to close bioethanol plant in Podari, Romania, and to downsize related activities in Germany Asset impairments of approximately CHF 110 million and provisions relating to closure of approximately CHF 60 – 90 million in Q4 2023Anticipated cash impact of CHF 110 – 140 million in 2024Continued focus on execution of Clariant’s purpose-led growth strategy MUTTENZ, DECEMBER 6, 2023 Clariant, a sustaina